Basic Information
RNALocate ID: | RLID:11003783 |
RNA Symbol: | hsa-miR-149-3p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-149-3p |
RNA ID: | miRBase:MIMAT0004609 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 23663360 |
Tissue/Cell Line: | Plasma |
Method: | Next-generation RNA sequencing |
Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01002607 | Mitochondrion | Cell line (HEK-293) | 22984580 |
RLID:11003781 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
RLID:11003782 | Exosome | B cell line (Raji)|Jurkat-derived T cell line (J77cl20) | 21505438 |
RLID:11003784 | Exosome | K562 cells | 24460325 |
RLID:11003785 | Exosome | Breast cancer cell lines (MCF-7|MDA-MB-231) | 24468161 |
RLID:11003786 | Microvesicle | Seminal plasma | 23539611 |
RLID-D:11000639 | Microvesicle | Fibroblasts|Mesenchymal stem cells | |
RLID-D:11001514 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-149-3p | Oral squamous cell carcinoma | MNDR-E-MI-16266 |
MNDR | hsa-miR-149-3p | Medulloblastoma | MNDR-E-MI-16267 |
MNDR | hsa-miR-149-3p | Lymphoma | MNDR-E-MI-16268 |
MNDR | hsa-miR-149-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-16269 |
MNDR | hsa-miR-149-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-16270 |
MNDR | hsa-miR-149-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-16271 |
MNDR | hsa-miR-149-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-16272 |
MNDR | hsa-miR-149-3p | Her2-receptor positive breast cancer | MNDR-E-MI-16273 |
MNDR | hsa-miR-149-3p | Breast cancer luminal | MNDR-E-MI-16274 |
MNDR | hsa-miR-149-3p | Prostate cancer | MNDR-E-MI-16275 |
MNDR | hsa-miR-149-3p | Gastric cancer | MNDR-E-MI-16276 |
MNDR | hsa-miR-149-3p | Intracranial aneurysm | MNDR-E-MI-16277 |
MNDR | hsa-miR-149-3p | Lung cancer | MNDR-E-MI-16278 |
MNDR | hsa-miR-149-3p | Parkinson disease | MNDR-E-MI-16279 |
MNDR | hsa-miR-149-3p | Basal-like breast cancer | MNDR-E-MI-16280 |
MNDR | hsa-miR-149-3p | Pancreatic cancer | MNDR-E-MI-16281 |
MNDR | hsa-miR-149-3p | HCV | MNDR-E-MI-16282 |
MNDR | hsa-miR-149-3p | Nephroblastoma | MNDR-E-MI-16283 |
MNDR | hsa-miR-149-3p | Colon cancer | MNDR-E-MI-16284 |
MNDR | hsa-miR-149-3p | Familial ovarian cancer | MNDR-E-MI-16285 |
MNDR | hsa-miR-149-3p | Glioblastoma | MNDR-E-MI-16286 |
MNDR | hsa-miR-149-3p | Glioma | MNDR-E-MI-16287 |
MNDR | hsa-miR-149-3p | Chordoma | MNDR-E-MI-16288 |
MNDR | hsa-miR-149-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-16289 |
MNDR | hsa-miR-149-3p | Osteosarcoma | MNDR-E-MI-16290 |
MNDR | hsa-miR-149-3p | Breast carcinoma | MNDR-E-MI-16291 |
MNDR | hsa-miR-149-3p | Infarction middle cerebral artery | MNDR-E-MI-16292 |
MNDR | hsa-miR-149-3p | Lung squamous cell carcinoma | MNDR-E-MI-16293 |
MNDR | hsa-miR-149-3p | Lung adenocarcinoma | MNDR-E-MI-16294 |
MNDR | hsa-miR-149-3p | Bladder urothelial carcinoma | MNDR-E-MI-16295 |
MNDR | hsa-miR-149-3p | Cholangiocarcinoma | MNDR-E-MI-16296 |
MNDR | hsa-miR-149-3p | Esophageal cancer | MNDR-E-MI-16297 |
MNDR | hsa-miR-149-3p | Lung small cell carcinoma | MNDR-E-MI-16298 |
MNDR | hsa-miR-149-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-16299 |
MNDR | hsa-miR-149-3p | Hepatocellular carcinoma | MNDR-E-MI-16300 |
MNDR | hsa-miR-149-3p | Familiar ovarian carcinoma | MNDR-E-MI-16301 |
MNDR | hsa-miR-149-3p | Retinoblastoma | MNDR-E-MI-16302 |
MNDR | hsa-miR-149-3p | Neuroblastoma | MNDR-E-MI-16303 |
MNDR | hsa-miR-149-3p | Hodgkin lymphoma | MNDR-E-MI-16304 |
MNDR | hsa-miR-149-3p | Colorectal cancer | MNDR-E-MI-16305 |
MNDR | hsa-miR-149-3p | Nasopharynx carcinoma | MNDR-E-MI-16306 |
MNDR | hsa-miR-149-3p | Nasopharyngeal cancer | MNDR-E-MI-16307 |
MNDR | hsa-miR-149-3p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-16308 |
MNDR | hsa-miR-149-3p | Stroke lacunar | MNDR-E-MI-16309 |
MNDR | hsa-miR-149-3p | Breast cancer her3+ negative | MNDR-E-MI-16310 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | AKT1 | Homo sapiens | RR00066993 |
TOP